Influence of Non-steroidal Anti-inflammatory Drugs on the Binding Kinetics of Dansylsarcosine to Human Serum Albumin: Stereoselectivity, steric and inductive effects

Arzneimittel-Forschung/Drug Research

Volumn 46, Issue 2, 1996, Pages 164-168

  Keita, Yango ^a   Wörner, Wolfgang ^a   Veile, Guido ^a   Woodcock, Barry G ^a   Fuhr, Uwe ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Anti inflammatories; Effect on protein binding kinetics; Inductive and steric effects; Nonsteroidal; Protein binding; Stereoselectivity

Indexed keywords

BENZODIAZEPINE RECEPTOR; BENZODIAZEPINE RECEPTOR AFFECTING AGENT; DANSYLSARCOSINE; DICLOFENAC; FENBUFEN; FLURBIPROFEN; GLYCOSYLATED PROTEIN; HUMAN SERUM ALBUMIN; IBUPROFEN; KETOPROFEN; MEFENAMIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; UNCLASSIFIED DRUG;

ARTICLE; BINDING KINETICS; CONTROLLED STUDY; DISSOCIATION CONSTANT; ENANTIOMER; GLYCATION; PLASMA PROTEIN BINDING; PROTEIN MODIFICATION; STEREOSPECIFICITY; STRUCTURE ACTIVITY RELATION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DANSYL COMPOUNDS; HUMANS; PROTEIN BINDING; SARCOSINE; SERUM ALBUMIN; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0029876084     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Cohen, M. P., Eur. J. Chem. Clin. Biochem. 30, 851 (1992)
2. Tsuchiya, S., Tamiko, S., Sekiguchi, S., Biochem. Pharmacol. 33, 2967 (1984)
3. Shaklai, N., Garlick, R. L., Bunn, H., J. Biol. Chem. 259, 3812 (1984)
4. Keita, Y., Kratzer, W., Wörner, W. et al., Int. J. Clin. Pharmacol. Ther. Toxicol. 31, 337 (1993)
5. Sudlow, G., Birkett, D. J., Wade, D. N., Mol. Pharmacol. 12, 1052 (1976)
6. He, X. M., Carter, D. C., Nature 358, 209 (1992)
7. Müller, W. E., in: Drugs Stereochemistry Analytical Methods and Pharmacology, I. W. Wainer, D. E. Drayer (eds.), Marcel Dekker. New York (1988)
8. Hutt, A. J., Caldwell, J., Clin. Pharmacokin. 9, 371 (1984)
9. Ariens, E. J., Eur. J. Clin. Pharmacol. 26, 663 (1984)
10. Ariens, E. J., in: Stereochemistry and Biological Activity of Drugs, E. J. N. Ariens, W. Soudijn, P. B. M. W. M. Timmermans (eds.), pp. 11-32, Blackwell Scientific Publications, Oxford-London etc. (1983)
11. Knabe, J., Arzneim.-Forsch./Drug Res. 39 (II), 1379 (1989)
12. Wanwimolruk, S., Brooks, P. M., Birkett, D. J., Br. J. Clin. Pharmacol. 15, 91 (1983)
13. Siebler, D., Kinawi, A., Arzneim.-Forsch./Drug Res. 39 (I), 659 (1989)
14. Evans, A. M., Nation, R. L., Sansom, L. N. et al., Eur. J. Clin. Pharmacol. 36, 283 (1989)
15. Berry, B. W., Jamali, F., J. Pharm. Sci. 78, 632 (1989)
16. Geisslinger, G., Stock, K. P., Bach, G. L. et al., Agents Actions 27, 455 (1989)
17. Geisslinger, G., Schuster, O., Sock, K.-P. et al., Eur. J. Clin. Pharmacol. 38, 493 (1990)
18. Chen, C. S., Shieh, W.-R., Lu, P.-H., Biochim. Biophys. Acta 1078, 411 (1991)
19. Wanwimolruk, S., Birkett, D. J., Brooks, P. M., Mol. Pharmacol. 24, 458 (1983)
20. Jähnchen, E., Müller, W. E., in: Topics in Pharmaceutical Sciences, D. D. Breimer, P. Speiser (eds.), Elsevier, Amsterdam (1983)
21. Müller, W. E., Wollert, U., Mol. Pharmacol. 11, 52 (1975)
22. Laßmann, A., in: Progress in Drug Protein Binding, N. Rietbrock, B. G. Woodcock (eds.), pp. 17-29, Vieweg, Braunschweig (1981)
23. Ulrich, R., Laßmann, A., Kaufmann, R., Rietbrock, N., Fresenius Z. Anal. Chem. 415, 534 (1983)
24. Bos, O. J. M., Fischer, M. J. E., Wilting, J. et al., Biochem. Pharmacol. 38, 1979 (1989)
25. Bernasconi, C. F., in: Relaxation Kinetics, C. F. Bernasconi (ed.), pp. 20-39, Academic Press, New York (1983)
26. Rendic, S., Alebic-Kolbah, T., Kajfez, F. et al., Farmaco. Sci. 35, 51 (1980)
27. Knadler, M. P., Brader, D. C., Hall, S. D., Clin. Pharmacol. Ther. 44, 135 (1988)
28. Oravcova, J., Mlynarik, V., Bystricky, S. et al., Chirality 3, 412 (1991)
29. Izumi, Y., Angew. Chem. 83, 956 (1971); Angew. Chem. Int. Ed. Engl. 10, 871 (1971)
30. Izumi, Y., Angew. Chem. 83, 956 (1971); Angew. Chem. Int. Ed. Engl. 10, 871 (1971)
31. March, J., in: Advanced Organic Chemistry Reactions, Mechanisms and Structure, N. Williams (ed.), pp. 16-18, 239-242, Wiley & Sons, New York-Chichester (1985)
32. Netter, P., Bannwarth, B., Royer-Morrot, M.-J., Clin. Pharmacokinet. 17, 145 (1989)
33. Murayama, T., Lin, C. C., Yamsaki, K. et al., Biochem. Pharmacol. 45, 1017 (1993)
34. Li, K. L., Thakur, A. K., Kapoor, A. L., J. Pharm. Sci. 77, 251 (1988)
35. Oida, T., J. Biochem. 100, 99 (1986)
36. Kearns, G. L., Kemp, S. F., Smith, J. V. J. Clin. Pharmacol. 31, 867 (1991)
37. Bohney, J. P., Feldhoff, R. C., Biochem. Pharmacol. 43, 1829 (1992)
38. Wörner, W., Preissner, A., Rietbrock, N., Eur. J. Clin. Pharmacol. 43, 97 (1992)
39. Fitos, I., Visy, J., Simonyi, M., Biochem. Pharmacol. 41, 377 (1991)
40. Dubois, N., Lapicque, F., Abiteboul, M. et al., Chirality 5, 126 (1993)
41. Hayball, P. J., Nation, R. L., Bochner, F. et al., Chirality 3, 460 (1991)